Delivery Order SPE2DB20D7059-SPE2DB23FQAR8
Award Date 4/17/23
Potential Completion Date 4/18/23
Potential Value $2.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,499.27 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Clarithromycin 125 mg/5 ml suspension in 100 ml bottles. This contract has a completion date of January 18, 2023 and is structured as a Firm Fixed Price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,668 units of Clarithromycin 500 mg tablets, a pharmaceutical drug, with a ceiling value of $1,143.66. The contract has an ultimate completion date of November 2, 2023, and was awarded on November 1, 2023. The contract is a firm fixed-price, delivery order type, with no set-aside designation....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Clarithromycin 500 mg tablets, a generic antibiotic medication. The contract has a firm fixed price of $1,667.49 and an ultimate completion date of May 31, 2024. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,266.28 firm fixed-price delivery order is for the supply of 4,566,658,239 units of Clarithromycin 500 mg tablets. The contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,272,269 tablets of Clarithromycin 500 mg to the U.S. Department of Defense (DoD). The contract, a Delivery Order with a Firm Fixed Price pricing type, has a ceiling value of $1,035.37 and a completion date of April 16, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,126.83 Firm Fixed Price Delivery Order contract is for the provision of 60-count bottles of Clarithromycin 500 mg tablets. The contract has a period of performance through May 5, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of 4,560,070,715 tablets of Clarithromycin 500 mg to the Defense Logistics Agency (DLA). The contract, valued at $1,157.91, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on February 27, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is February 28, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award, with ID SPE2DX15D6028 and SPE2DX23FWUMG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,763,142 units of the pharmaceutical product Clarithromycin 500mg, 60 capsules, with a ceiling value of $13,469.28. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of...
- This federal contract award, valued at $1,106.77, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of Clarithromycin 500 mg tablets, a brand name antibiotic medication. This award is associated with a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued at up...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,890.89 firm-fixed-price delivery order is for 4,562,911,847 tablets of the antibiotic Clarithromycin 500 mg. The contract has an ultimate completion date of November 28, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB23FQAR8Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., for the supply of Clarithromycin 500 mg tablets. The contract has a ceiling value of $2,634.94 and an ultimate completion date of April 18, 2023. This delivery order is part of a larger, $999,999,999.00 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded without any set-aside designation, indicating full and open competition.
Generated 5/9/25, 9:47 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 4/17/23 |